These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


357 related items for PubMed ID: 229884

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunity status to poliovirus in Veneto region (north-east Italy). A seroepidemiological survey.
    Trivello R, Farisano G, Bonello C, Moschen ME, Baldo V, Majori S, Moretti G, Marin V, Piron L, Renzulli G.
    Ann Clin Lab Sci; 1994; 24(6):542-7. PubMed ID: 7847782
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Humoral immunity status against poliomyelitis in the Piedmont population 15 years after the introduction of vaccination with Sabin oral vaccine].
    Giuliani G, Frezet D, Paggi GC, Varetti G.
    Ann Sclavo; 1982; 24(1):5-15. PubMed ID: 6303233
    [No Abstract] [Full Text] [Related]

  • 7. [A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong].
    Xu A.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):261-4. PubMed ID: 1338626
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A seroprevalence study of poliovirus antibody in the population of northern Greece.
    Frantzidou F, Diza E, Halkia D, Antoniadis A.
    Clin Microbiol Infect; 2005 Jan; 11(1):68-71. PubMed ID: 15649308
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [IgM-specific neutralizing antibodies against poliovirus in cases of poliomyelitis].
    Salmerón García F.
    Bol Oficina Sanit Panam; 1982 Mar; 92(3):203-7. PubMed ID: 6279126
    [No Abstract] [Full Text] [Related]

  • 20. A seroprevalence study of poliovirus antibody against a collection of recombinant and non-recombinant poliovirus vaccine strains in the population of southern Greece.
    Pliaka V, Ruether IG, Kyriakopoulou Z, Kioussi P, Plakokefalos E, Megalou M, Pratti A, Levidiotou-Stefanou S, Markoulatos P.
    Clin Microbiol Infect; 2010 Nov; 16(11):1672-5. PubMed ID: 20148919
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.